Nissay Asset Management Corp Japan ADV Sells 1,718 Shares of Stryker Co. (NYSE:SYK)

Nissay Asset Management Corp Japan ADV lessened its stake in Stryker Co. (NYSE:SYK) by 3.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,549 shares of the medical technology company’s stock after selling 1,718 shares during the period. Nissay Asset Management Corp Japan ADV’s holdings in Stryker were worth $19,658,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in SYK. Nomura Holdings Inc. grew its stake in Stryker by 220.2% in the 4th quarter. Nomura Holdings Inc. now owns 15,925 shares of the medical technology company’s stock worth $5,734,000 after acquiring an additional 10,951 shares in the last quarter. Nearwater Capital Markets Ltd bought a new position in shares of Stryker during the fourth quarter valued at approximately $36,304,000. NorthRock Partners LLC boosted its stake in shares of Stryker by 375.4% during the fourth quarter. NorthRock Partners LLC now owns 15,578 shares of the medical technology company’s stock valued at $5,609,000 after purchasing an additional 12,301 shares in the last quarter. Obermeyer Wealth Partners bought a new position in shares of Stryker during the fourth quarter valued at approximately $957,000. Finally, MayTech Global Investments LLC boosted its stake in shares of Stryker by 10.0% during the fourth quarter. MayTech Global Investments LLC now owns 41,116 shares of the medical technology company’s stock valued at $14,804,000 after purchasing an additional 3,749 shares in the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director now owns 3,417,326 shares of the company’s stock, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now directly owns 14,895 shares of the company’s stock, valued at $5,705,827.65. The trade was a 14.16% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SYK. JMP Securities reiterated a “market perform” rating on shares of Stryker in a research note on Monday, May 5th. Sanford C. Bernstein set a $450.00 price objective on shares of Stryker in a research note on Monday, May 5th. Truist Financial increased their target price on shares of Stryker from $390.00 to $400.00 and gave the company a “hold” rating in a research report on Monday, May 5th. BTIG Research set a $403.00 target price on shares of Stryker and gave the company a “buy” rating in a research report on Monday, April 14th. Finally, Roth Mkm increased their target price on shares of Stryker from $405.00 to $456.00 and gave the company a “buy” rating in a research report on Friday, May 2nd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and a consensus target price of $427.05.

Stryker Trading Down 0.3%

Shares of Stryker stock opened at $386.42 on Thursday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The firm has a fifty day moving average price of $365.58 and a 200 day moving average price of $374.90. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The stock has a market cap of $147.49 billion, a PE ratio of 49.80, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The firm had revenue of $5.87 billion during the quarter, compared to analysts’ expectations of $5.68 billion. During the same quarter last year, the company posted $2.50 earnings per share. The firm’s revenue was up 11.9% compared to the same quarter last year. Equities research analysts predict that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.87%. Stryker’s payout ratio is 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.